SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-13-041165
Filing Date
2013-07-23
Accepted
2013-07-23 19:12:58
Documents
1
Period of Report
2013-07-23

Document Format Files

Seq Description Document Type Size
1 rrd386056.html 4  
1 rrd386056.xml 4 15378
  Complete submission text file 0001181431-13-041165.txt   17493
Mailing Address 50 PUBLIC SQUARE SUITE 2700 CLEVELAND OH 44113
Business Address 50 PUBLIC SQUARE SUITE 2700 CLEVELAND OH 44113 216-416-7500
MORGENTHALER PARTNERS VII LP (Reporting) CIK: 0001162183 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-35993 | Film No.: 13982252

Mailing Address 800 CHESAPEAKE DRIVE REDWOOD CITY CA 94063
Business Address 800 CHESAPEAKE DRIVE REDWOOD CITY CA 94063 650-995-8200
OncoMed Pharmaceuticals Inc (Issuer) CIK: 0001302573 (see all company filings)

IRS No.: 383572512 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 50 PUBLIC SQUARE SUITE 2700 CLEVELAND OH 44113
Business Address 50 PUBLIC SQUARE SUITE 2700 CLEVELAND OH 44113 216-416-7500
Morgenthaler Management Partners VII, LLC (Reporting) CIK: 0001379550 (see all company filings)

State of Incorp.: OH | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-35993 | Film No.: 13982251